You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (18) |
Back to Search
Treatment of arthritis with non-anticoagulant heparin lipid nanoparticles through suppression of the tlr4
- In: Posters C - Drug Design and Discovery
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PC-043
- By: BABAZADA, Hasan (Graduate School of Pharmaceutical Sciences, Kyoto University, Drug Delivery Research, Kyoto, Japan)
- Co-author(s): Yanamoto, Shinya (Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)
Yamashita, Fumiyoshi (Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)
Hashida, Mitsuru (Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan) - Abstract:
Rheumatoid arthritis is a chronic, systemic inflammatory disease, which damages synovium and leads to destruction of cartilage and bone loss. It was recently shown that TLR4
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026